百度智能雲下周一發布「文心一言」雲服務系列產品 已有逾十萬家企業申請測試
百度智能雲將於下周一(27日)舉行新品發布會,發布文心一言雲服務系列和應用產品。不同類型的企業可以依據自己需求,選取相應的雲服務和產品,方便、快捷、低成本地構建自己的模型和應用。
據了解,截至今日(20日)下午1時,文心一言發布四天已有21家企業完成首批簽約合作,申請文心一言API調用服務測試的企業已有逾10萬家。
目前,個人用戶可以進入文心一言官網參與排隊試用。企業用戶可以進入百度智能雲官網,申請預約文心一言API接口調用服務測試。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.